Notice of Registration - 2012
[Federal Register Volume 77, Number 20 (Tuesday, January 31, 2012)]
[Notices]
[Pages 4832-4833]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-1977]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 23, 2011, and published in the Federal
Register on July 5, 2011, 76 FR 39127, Cayman Chemical Company, 1180
East Ellsworth Road, Ann Arbor, Michigan 48108, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the following basic classes of controlled
substances:
| Drug |
Schedule |
| Cathinone (1235) |
I |
| Methcathinone (1237) |
I |
| N-Ethylamphetamine (1475) |
I |
| N,N-Dimethylamphetamine (1480) |
I |
| Aminorex (1585) |
I |
| 4-Methylaminorex (cis isomer) (1590) |
I |
| 1-Pentyl-3-(1-naphthoyl)indole (7118) |
I |
| 1-Butyl-3-(1-naphthoyl)indole (7173) |
I |
| 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) Indole (7200) |
I |
| Alpha-ethyltryptamine (7249) |
I |
| 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (7297) |
I |
| 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (7298) |
I |
| Lysergic acid diethylamide (7315) |
I |
| 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) |
I |
| Marihuana (7360) |
I |
| Tetrahydrocannabinols (7370) |
I |
| 3,4,5-Trimethoxyamphetamine (7390) |
I |
| 4-Bromo-2,5-dimethoxyamphetamine (7391) |
I |
| 4-Bromo-2,5-dimethoxyphenethylamine (7392) |
I |
| 4-Methyl-2,5-dimethoxyamphetamine (7395) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| 2,5-Dimethoxy-4-ethylamphetamine (7399) |
I |
| 3,4-Methylenedioxyamphetamine (7400) |
I |
| 5-Methoxy-3,4-methylenedioxyamphetamine (7401) |
I |
| N-Hydroxy-3,4-methylenedioxyamphetamine (7402) |
I |
| 3,4-Methylenedioxy-N-ethylamphetamine (7404) |
I |
| 3,4-Methylenedioxymethamphetamine (7405) |
I |
| 4-Methoxyamphetamine (7411) |
I |
| 5-Methoxy-N-N-dimethyltryptamine (7431) |
I |
| Alpha-methyltryptamine (7432) |
I |
| Diethyltryptamine (7434) |
I |
| Dimethyltryptamine (7435) |
I |
| 5-Methoxy-N,N-diisopropyltryptamine (7439) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Lisdexamfetamine (1205) |
II |
The company plans to manufacture small quantities of marihuana
derivatives for research purposes. In reference to drug code 7360
(Marihuana), the company plans to bulk manufacture cannabidiol. In
reference to drug code 7370 (Tetrahydrocannabinols), the company will
manufacture a synthetic THC. No other activity for this drug code is
authorized for this registration.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cayman Chemical Company to manufacture the listed basic classed of
controlled substances is consistent with the public interest at this
time. DEA has investigated Cayman Chemical Company to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance
with 21 CFR 1301.33, the above named company is granted registration as
a bulk manufacturer of the basic classes of controlled substances
listed.
Dated: January 23, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-1977 Filed 1-30-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
